JAMES OWENS: Open Payments
NPI 1063492528 · SALINA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$88,692 in 107 payments from 9 companies in 2025. Trend: 2023 $98,169 · 2024 $123,678 · 2025 $88,692
Speaker / faculty: $59,860Honoraria: $11,925Travel & lodging: $7,604Consulting: $7,460Food & beverage: $1,844
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 42 | $32,355 |
| Janssen Pharmaceuticals, Inc | 24 | $20,964 |
| ABBVIE INC. | 14 | $16,386 |
| Axsome Therapeutics, Inc. | 13 | $13,309 |
| Otsuka America Pharmaceutical, Inc. | 5 | $5,487 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $87 |
| Lundbeck LLC | 3 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: LYBALVI, INVEGA SUSTENNA, VRAYLAR, Auvelity, REXULTI, SPRAVATO, ARISTADA, CAPLYTA.
Industry payments across KS — which companies pay providers there.
